Co-Diagnostics, Inc

Co-Diagnostics, Inc (Co-Dx) was founded in 2013 with a mission to democratize access to molecular diagnostics and transform healthcare delivery on a global scale. The company's patented Co-Primers™ technology aims to innovate disease detection and life sciences research. Co-Dx is preparing to launch the Co-Dx PCR Pro™ instrument and tests, an at-home and point-of-care real-time PCR testing platform. This platform seeks to make high-quality real-time PCR diagnostics widely accessible, especially in remote areas, at the point-of-care, or at home, all at affordable prices. The company's slogan "the Power to Know" reflects its commitment to empowerment through access to accurate and affordable diagnostic technology. With a focus on bringing robust, high-quality, and affordable PCR technology to regions with the greatest need, Co-Diagnostics, Inc aims to have a positive impact on global healthcare. Co-Diagnostics, Inc is positioned to disrupt the molecular diagnostics industry and expand the availability of gold-standard infectious disease testing. However, the lack of specific information regarding industries, headquarters, and past investments leaves room for further evaluation of the company's growth and potential investors and partnerships.